Beyond Air files for $200M mixed securities shelf

Stock Information for Beyond Air Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Beyond Air Inc.

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit(TM) GO at Home
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer's Disease and Reinforcing Platform's Strength Across Neurological Disorders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.